Literature DB >> 9703897

Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines.

W S Koh1, S J Lee, H Lee, C Park, M H Park, W S Kim, S S Yoon, K Park, S I Hong, M H Chung, C H Park.   

Abstract

In order to investigate the differential effects of ascorbate derivatives on leukemic cell growth, we examined their stabilities and transmembrane transport efficiencies. The growth of HL-60 and U937 cells was dose-dependently inhibited by ascorbic acid and sodium ascorbate, but not by dehydroascorbic acid and magnesium ascorbyl 2-phosphate up to 200 microM. The growth-suppression by ascorbic acid was dependent on its redox state, showing a complete or partial reversion by ascorbate oxidase or FeCl3 addition, respectively. Three different patterns of intracellular ascorbic acid accumulation were observed by HPLC according to the species of ascorbate derivative applied for the incubation. Compared with the reduced form of ascorbic acid, the oxidized forms (dehydroascorbic acid, ascorbic acid plus ascorbate oxidase or FeCl3) were rapidly transported into cells and readily degraded, while magnesium ascorbyl 2-phosphate, a stable derivative of ascorbic acid, slowly elevated the intracellular level of ascorbic acid, reaching a plateau at 24 hours. We also measured the differential kinetics of ascorbic acid levels In culture supernatants following the addition of ascorbate derivatives. Ascorbic acid at 40, 10, or 1 microM was observed 3 hours following treatment with 100 microM of ascorbic acid, ascorbic acid plus FeCl3, or magnesium ascorbyl 2-phosphate, respectively. No ascorbic acid was found in the culture supernatant treated with dehydroascorbic acid. This order of ascorbic acid concentrations in culture supernatant reflects their growth-inhibitory effects. Thus the growth inhibitory effect of ascorbic acid appears to be dependent on its concentration in culture medium rather than its intracellular concentration. In conclusion, the results in this study indicate that the differential effects of ascorbate derivatives appear to be due to the actual concentration differences of the reduced form of ascorbic acid in culture medium following their addition, which is determined by their stability and efficiency of cellular uptake.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703897

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  22 in total

Review 1.  New insights into the physiology and pharmacology of vitamin C.

Authors:  S J Padayatty; M Levine
Journal:  CMAJ       Date:  2001-02-06       Impact factor: 8.262

2.  Ascorbate enhances the toxicity of the photodynamic action of Verteporfin in HL-60 cells.

Authors:  Galina G Kramarenko; Werner W Wilke; Disha Dayal; Garry R Buettner; Freya Q Schafer
Journal:  Free Radic Biol Med       Date:  2006-01-19       Impact factor: 7.376

3.  Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Authors:  Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

4.  In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7.

Authors:  M Waheed Roomi; Vadim Ivanov; Tatiana Kalinovsky; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

5.  Mechanism of DNA-protein cross-linking by chromium.

Authors:  Andrea Macfie; Elizabeth Hagan; Anatoly Zhitkovich
Journal:  Chem Res Toxicol       Date:  2010-02-15       Impact factor: 3.739

6.  Effect of a nutrient mixture on the localization of extracellular matrix proteins in HeLa human cervical cancer xenografts in female nude mice.

Authors:  M Waheed Roomi; John Cha; Tatiana Kalinovsky; Nusrath Roomi; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Exp Ther Med       Date:  2015-06-23       Impact factor: 2.447

7.  Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2.

Authors:  M Waheed Roomi; Vadim Ivanov; Tatiana Kalinovsky; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Int J Gastrointest Cancer       Date:  2005

Review 8.  Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer.

Authors:  A Niedzwiecki; M W Roomi; T Kalinovsky; M Rath
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

9.  Inhibition of cell invasion and MMP production by a nutrient mixture in malignant liposarcoma cell line SW-872.

Authors:  M W Roomi; V Ivanov; T Kalinovsky; Aleksandra Niedzwiecki; M Rath
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

10.  Enhancement of plasmacytoma cell growth by ascorbic acid is mediated via glucose 6-phosphate dehydrogenase.

Authors:  Woo Suk Koh; Woo Hyuck Choi; Sook Ja Lee; Chaehwa Park; Chan H Park
Journal:  Cancer Res Treat       Date:  2007-03-31       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.